|
|
Home > Healthcare > Biotechnology > Genetics & Genomics
Next Generation Sequencing for Life Science R&D: Advancing to the $1,000 Genome
|
|
This report examines the emerging, fast-growing worldwide market for next-generation genome sequencing systems and services. The makers of the new sequencing systems are competing in the race to drive down the cost of sequencing a human genome to $1,000 or less. At that cost, life scientists will be able sequence human genomes at the massive scale needed to better understand human variation and help open the gateway to personalized medicine.
The first wave of the commercial high-throughput genome sequencers has seen a rapid uptake from life science research customers at genome centers and research service providers from North America, Europe and Asia. This study looks at the basic technologies that these new DNA sequencers use and what kinds of applications and research projects that the scientists are doing.
The new platforms can help accelerate the research capabilities of basic academic medical research, pharmaceutical and biotech drug discovery and diagnostic developments. The report also studies the research service providers that outsource to pharma and biotech companies because the technologies might help them become more productive faster.
This report is for business executives, entrepreneurs, venture capitalists, investors, product managers, research managers, business development managers, and other decision makers. The next-generation genome sequencing products and services discussed include technologies from Illumina, Roche/ 454, Applied Biosystems, Danaher Motion, Helicos Biosciences, Pacific Biosciences and others.
This study discusses its interesting topics with key findings. The new data presented estimates that the total next-generation genome sequencing market size will reach $484 million in 2008 and grow at a high rate. It reviews the activities of 18 companies. The report uses 38+ figures and tables to illustrate the findings. The study features convenient tables that help the reader scan the details of key trends, market segmentation, forecasts, M&As, alliances, grant funding, patents and the like.
|
Similar Products
• Biotechnology Sector
Published Nov 2009 by First Research, Inc.
• Dealmaking and Industry Outlook: Neurological Disease
Published Nov 2009 by Decision Resources
• Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Published Oct 2009 by BioSeeker Group AB
• Plunkett's Health Care Technologies Overview 2010 (Summary)
Published Oct 2009 by Plunkett Research, Ltd.
• The Human Genome Sequencing Center at Baylor College of Medicine Relies on Quantum's StorNext Software for Data Management
Published Oct 2009 by IDC
• Three Alternative Scenarios Of The Future In Vitro Diagnostics Market 2009-2018
Published Oct 2009 by Venture Planning Group
• Preventive Healthcare Technologies, Products and Markets
Published Oct 2009 by BCC Research
• Transfection Life Science Dashboard™ Series 2
Published Oct 2009 by Percepta Associates, Inc.
• Genealogy Products and Services
Published Oct 2009 by Global Industry Analysts
• Advances in the Use of Biomarkers in Biochip and Microarray Testing: Innovative technologies, growth opportunities and the future market outlook
Published Oct 2009 by Business Insights
|
|
|
|
0 items
